scispace - formally typeset
Open AccessJournal ArticleDOI

Effects of Dantrolene on Steps of Excitation-Contraction Coupling in Mammalian Skeletal Muscle Fibers

Reads0
Chats0
TLDR
Dantrolene was found to suppress the depolarization-induced elevation in intracellular calcium concentration ([Ca2+]i) by inhibiting the release of calcium from the SR by binding on the SR membrane, but be distinct from the purified RYR itself.
Abstract
The effects of the muscle relaxant dantrolene on steps of excitation-contraction coupling were studied on fast twitch muscles of rodents. To identify the site of action of the drug, single fibers for voltage-clamp measurements, heavy SR vesicles for calcium efflux studies and solubilized SR calcium release channels/RYRs for lipid bilayer studies were isolated. Using the double Vaseline-gap or the silicone-clamp technique, dantrolene was found to suppress the depolarization-induced elevation in intracellular calcium concentration ([Ca2+]i) by inhibiting the release of calcium from the SR. The suppression of [Ca2+]i was dose-dependent, with no effect at or below 1 μM and a 53 ± 8% (mean ± SEM, n = 9, cut fibers) attenuation at 0 mV with 25 μM of extracellularly applied dantrolene. The drug was not found to be more effective if injected than if applied extracellularly. Calculating the SR calcium release revealed an equal suppression of the steady (53 ± 8%) and of the early peak component (46 ± 6%). The drug did not interfere with the activation of the voltage sensor in as much as the voltage dependence of both intramembrane charge movements and the L-type calcium currents (ICa) were left, essentially, unaltered. However, the inactivation of ICa was slowed fourfold, and the conductance was reduced from 200 ± 16 to 143 ± 8 SF−1 (n = 10). Dantrolene was found to inhibit thymol-stimulated calcium efflux from heavy SR vesicles by 44 ± 10% (n = 3) at 12 μM. On the other hand, dantrolene failed to affect the isolated RYR incorporated into lipid bilayers. The channel displayed a constant open probability for as long as 30–50 min after the application of the drug. These data locate the binding site for dantrolene to be on the SR membrane, but be distinct from the purified RYR itself.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Dantrolene – A review of its pharmacology, therapeutic use and new developments

TL;DR: Dantrolene is not only used for the treatment of malignant hyperthermia, but also in the management of neuroleptic malignant syndrome, spasticity and Ecstasy intoxication, and its main disadvantage is its poor water solubility, and hence difficulties are experienced in rapidly preparing intravenous solutions in emergency situations.
Journal ArticleDOI

Identification of a Dantrolene-binding Sequence on the Skeletal Muscle Ryanodine Receptor

TL;DR: The results indicate that synthetic domain peptides can mimic a native, ligand-binding conformation in vitro and that the dantrolene-binding site and the epitope for the monoclonal antibody on RyR1 are equivalent and composed of amino acids 590–609.
Journal ArticleDOI

Dantrolene stabilizes domain interactions within the ryanodine receptor.

TL;DR: The results suggest that the mechanism of action of dantrolene involves stabilization of domain-domain interactions within the domain switch, preventing domain unzipping-induced channel dysfunction.
Journal ArticleDOI

Checking your SOCCs and feet: the molecular mechanisms of Ca2+ entry in skeletal muscle.

TL;DR: This review highlights recent findings regarding the molecular identity, subcellular localization, and inter‐relationship between SOCE and ECCE in skeletal muscle.
Journal ArticleDOI

The Skeletal L-type Ca2+ Current Is a Major Contributor to Excitation-coupled Ca2+ entry

TL;DR: Results indicate that the skeletal muscle L-type channel is a major contributor to the Ca2+ entry attributed to ECCE, and the transients in dysgenic myotubes expressing SkEIIIK had a time course like that of normal myot tubes in Ca2-free solution and were unaffected by Ca2+.
References
More filters
Journal ArticleDOI

Calcium release from skeletal muscle sarcoplasmic reticulum: site of action of dantrolene sodium

TL;DR: The muscle relaxant dantrolene sodium markedly suppresses the release of calcium previously sequestered by skeletal, but not cardiac, muscle sarcoplasmic reticulum, and may reduce the amount of calcium necessary for muscle contraction in situ.
Journal ArticleDOI

Dantrolene Inhibition of Sarcoplasmic Reticulum Ca2+Release by Direct and Specific Action at Skeletal Muscle Ryanodine Receptors

TL;DR: Evidence is provided of a high-affinity, monophasic inhibition by dantrolene of ryanodine receptor Ca2+ channel function in isolated sarcoplasmic reticulum vesicles prepared from malignant hyperthermia-susceptible and normal pig skeletal muscle and a mechanism of action is suggested in which danterolene may act directly at the skeletal muscle ryanODine receptor complex to limit its activation by calmodulin and Ca2+.
Journal ArticleDOI

Sarcoplasmic reticulum lumenal Ca2+ has access to cytosolic activation and inactivation sites of skeletal muscle Ca2+ release channel.

TL;DR: It is suggested that lumenal Ca2+ flowing through the skeletal muscle Ca 2+ release channel may regulate channel activity by having access to cytosolicCa2+ activation and Ca2- inactivation sites that are located in "BAPTA-inaccessible" and "B APTA-accessible" spaces, respectively.
Journal ArticleDOI

Measurement and modification of free calcium transients in frog skeletal muscle fibres by a metallochromic indicator dye.

TL;DR: Myoplasmic free calcium transients were monitored with the metallochromic indicator dye Antipyrylazo III in single frog skeletal muscle fibres cut at both ends, stretched so as to minimize or eliminate contractile filament overlap and voltage clamped using a double‐Vaseline‐gap system.
Related Papers (5)